Cargando…
Re-Validation of the COmprehensive Score for Financial Toxicity (COST): Assessing the Scale’s Utility in Chronic Disease Populations
OBJECTIVE: To report the psychometric properties of the COmprehensive Score for financial Toxicity (COST) patient-reported outcome measure (PROM), an 11-item scale previously validated among patients diagnosed with cancer and receiving chemotherapy. METHODS: Data come from a cross-sectional survey (...
Autores principales: | Pavela, G, Fifolt, M, Tison, SE, Allison, M, Burton, BS, Ford, EW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669122/ https://www.ncbi.nlm.nih.gov/pubmed/34916802 http://dx.doi.org/10.1177/11786329211057352 |
Ejemplares similares
-
Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)
por: de Souza, Jonas A., et al.
Publicado: (2016) -
Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors
por: Shim, Sungkeun, et al.
Publicado: (2022) -
Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer
por: Honda, Kazunori, et al.
Publicado: (2019) -
Validation of the comprehensive score for financial toxicity for Brazilian culture
por: de Alcantara Nogueira, Luciana, et al.
Publicado: (2020) -
Assessing the reliability and validity of comprehensive score for financial toxicity (COST) among radiation oncology patients in India: a cross-sectional pilot study
por: Dar, Mukhtar Ahmad, et al.
Publicado: (2021)